Literature DB >> 34302853

Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors.

Neil B Varshneya1, D Matthew Walentiny2, Lea T Moisa2, Teneille D Walker3, Luli R Akinfiresoye3, Patrick M Beardsley4.   

Abstract

Synthetic opioids have been implicated as the single greatest contributor to rising drug-related fatalities in recent years. This study evaluated mu-opioid receptor (MOR) mediated effects of seven fentanyl-related substances that have emerged in the recreational drug marketplace, and for which there are no existing or only limited in vivo data. Adult male Swiss Webster mice were administered fentanyl-related substances and their effects on nociception and locomotion as compared to MOR agonist standards were observed. In locomotor activity tests, morphine (100, 180 mg/kg), fentanyl (1, 10 mg/kg), beta-methylfentanyl (10 mg/kg), para-methoxyfentanyl (10 mg/kg), fentanyl carbamate (100 mg/kg), and 3-furanylfentanyl (10 mg/kg), elicited significant (p ≤ 0.05) dose-dependent increases in locomotion. However, para-methylfentanyl and beta'-phenylfentanyl did not produce significant effects on locomotion at doses up to 100 mg/kg and phenylfentanyl (100 mg/kg) significantly decreased locomotion. In warm-water tail-withdrawal tests, all substances produced significant dose-dependent increases in antinociception with increasing ED50 values (95% CI) of fentanyl [0.08 mg/kg (0.04-0.16)] > para-methoxyfentanyl [0.43 mg/kg (0.23-0.77)] > 3-furanylfentanyl [0.51 mg/kg (0.36-0.74)] > beta-methylfentanyl [0.74 mg/kg (0.64-0.85)] > para-methylfentanyl [1.92 mg/kg (1.48-2.45)] > fentanyl carbamate [5.59 mg/kg (4.11-7.54)] > morphine [7.82 mg/kg (5.42-11.0)] > beta'-phenylfentanyl [19.4 mg/kg (11.0-34.4)] > phenylfentanyl [55.2 mg/kg (33.5-93.0)]. Naltrexone (1 mg/kg) increased ED50 values several fold with decreasing magnitudes of para-methylfentanyl (63.1×) > para-methoxyfentanyl (22.5×) > beta'-phenylfentanyl (21.0×) > 3-furanylfentanyl (20.6×) > beta-methylfentanyl (19.2×) > phenylfentanyl (5.23×) > fentanyl (3.95×) > fentanyl carbamate (2.21×) > morphine (1.48×). These findings expand upon in vivo results from previous studies and establish that the effects of these fentanyl related-related substances are at least in part mediated by the MOR.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Analgesia; Analog; Fentanyl; Locomotion; Mice; Opioid

Mesh:

Substances:

Year:  2021        PMID: 34302853      PMCID: PMC9044821          DOI: 10.1016/j.pbb.2021.173242

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.697


  29 in total

1.  Structure-activity studies of fentanyl.

Authors:  A F Casy; M R Huckstep
Journal:  J Pharm Pharmacol       Date:  1988-09       Impact factor: 3.765

2.  Drug Overdose Deaths Involving Fentanyl, 2011-2016.

Authors:  Merianne R Spencer; Margaret Warner; Brigham A Bastian; James P Trinidad; Holly Hedegaard
Journal:  Natl Vital Stat Rep       Date:  2019-03

3.  [Studies on potent analgesics. I. Synthesis and analgesic activity of derivatives of fentanyl (author's transl)].

Authors:  Y Q Zhu; G L Ge; S N Fang; Y C Zhu; Q Y Dai; Z Y Tan; Z M Huang; X J Chen
Journal:  Yao Xue Xue Bao       Date:  1981-03

4.  Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004).

Authors:  Teri L Martin; Karen L Woodall; Barry A McLellan
Journal:  J Anal Toxicol       Date:  2006-10       Impact factor: 3.367

5.  Characterizing fentanyl use in methadone-maintained clients.

Authors:  Cynthia L Arfken; Jessica Suchanek; Mark K Greenwald
Journal:  J Subst Abuse Treat       Date:  2017-01-14

Review 6.  Abuse of fentanyl: An emerging problem to face.

Authors:  Katarzyna Kuczyńska; Piotr Grzonkowski; Łukasz Kacprzak; Jolanta B Zawilska
Journal:  Forensic Sci Int       Date:  2018-06-02       Impact factor: 2.395

Review 7.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

8.  Fentanyl concentrations in 23 postmortem cases from the hennepin county medical examiner's office.

Authors:  Jonathan G Thompson; Andrew M Baker; Anne H Bracey; Justin Seningen; Julie S Kloss; A Quinn Strobl; Fred S Apple
Journal:  J Forensic Sci       Date:  2007-06-06       Impact factor: 1.832

Review 9.  An Expanding World of Novel Psychoactive Substances: Opioids.

Authors:  Jolanta B Zawilska
Journal:  Front Psychiatry       Date:  2017-06-30       Impact factor: 4.157

10.  The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City.

Authors:  Suky Martinez; Jermaine D Jones; Laura Brandt; Aimee N C Campbell; Rebecca Abbott; Sandra D Comer
Journal:  Am J Addict       Date:  2020-08-10
View more
  4 in total

1.  Opioid-like adverse effects of tianeptine in male rats and mice.

Authors:  T R Baird; H I Akbarali; W L Dewey; H Elder; M Kang; S A Marsh; M R Peace; J L Poklis; E J Santos; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2022-02-24       Impact factor: 4.530

2.  Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated.

Authors:  Neil B Varshneya; Sherif H Hassanien; Melissa C Holt; David L Stevens; Nathan K Layle; Jonathon R Bassman; Donna M Iula; Patrick M Beardsley
Journal:  Biochem Pharmacol       Date:  2021-10-19       Impact factor: 6.100

3.  Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.

Authors:  Edna J Santos; Matthew L Banks; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2022-04-30       Impact factor: 4.402

Review 4.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.